3M™ Inadine™ (PVP-I) Non Adherent Dressing

3M ID B5005265097

Protects and minimises adherence to the wound bed, and provides an antiseptic effect against bacterial organisms (In-Vitro)¹¯⁵

Protects and minimises adherence to the wound bed, therefore reducing the risk of damage to the granulation tissue at dressing removal, and in clinical practice has been shown to reduce pain for patients.¹¯³

Has broad spectrum antimicrobial effect (In-Vitro). Povidone Iodine molecule has a broad-spectrum antimicrobial action⁴ and has been proven to be effective against MRSA.⁵’⁶

View more details

Details

Highlights

Protects and minimises adherence to the wound bed, and provides an antiseptic effect against bacterial organisms (In-Vitro)¹¯⁵
Protects and minimises adherence to the wound bed, therefore reducing the risk of damage to the granulation tissue at dressing removal, and in clinical practice has been shown to reduce pain for patients.¹¯³
Has broad spectrum antimicrobial effect (In-Vitro). Povidone Iodine molecule has a broad-spectrum antimicrobial action⁴ and has been proven to be effective against MRSA.⁵’⁶

3M™ Inadine™ (PVP-I) Non-Adherent Dressing is a topical wound dressing made of low adherent viscose fabric impregnated with an ointment containing polyethylene glycol (PEG), purified water and 10% povidone iodine (PVP-I).

When to use it?

Inadine Dressing is indicated for the management of ulcerative wounds, minor burns and minor traumatic skin loss injuries. Inadine dressing is designed to protect and minimize adherence to the wound bed and provides an antiseptic effect against bacterial organisms.

Clinical studies suggest that Inadine Dressing may also be an appropriate dressing choice in the management of chronic wounds, including:

Ulcers deriving from different aetiologies¹

Diabetic foot ulcers¹ ⁸

Pressure ulcers⁴

Suggested applications

Ulcers deriving from different aetiologies¹
Diabetic foot ulcers¹ ⁸
Pressure ulcers⁴

Specifications

Details

Legal disclaimer

¹ Sibbald RG, Leaper DJ, Queen D. Iodine Made Easy. Wounds International. 2011;2(2). ² Vowden P and Cooper RA. An integrated approach to managing wound infection. Position Document: Management of wound infection. European Wound Management Association (EWMA). 2006; London, UK. ³ Gordon J. Clinical significance of methicillin-sensitive and methicillin resistant Staphylococcus aureus in UK hospitals and the relevance of povidone iodine in their control. Postgraduate Medical Journal. 1993; 69(3):106-116. ⁴ Langley SRN. Inadine wound dressings speed healing, reduce patient discomfort and cuts costs by almost 40%. Burns. 1989; Vol.15. ⁵ Han KH et al. Management of partial skin thickness burn wounds with Inadine® dressings. Burns. 1989; 15(6):399-402. ⁶ Campbell N, Campbell D et al. Evaluation of a non-adherent, povidone– iodine dressing in a case series of chronic wounds. Journal of Wound Care. 2013; 22(8):401-2,404-6.